Search

Your search keyword '"Yamaguchi, Tatsumi"' showing total 18 results
Start Over Author "Yamaguchi, Tatsumi"
18 results on '"Yamaguchi, Tatsumi"'

1. Cell-Free Synthesis of Human Endothelin Receptors and Its Application to Ribosome Display

Author

Nakai, Hiroki, primary, Isshiki, Kinuka, additional, Hattori, Masato, additional, Maehira, Hiromasa, additional, Yamaguchi, Tatsumi, additional, Masuda, Keiko, additional, Shimizu, Yoshihiro, additional, Watanabe, Takayoshi, additional, Hohsaka, Takahiro, additional, Shihoya, Wataru, additional, Nureki, Osamu, additional, Kato, Yasuhiko, additional, Watanabe, Hajime, additional, and Matsuura, Tomoaki, additional

Published
2022
Full Text
View/download PDF

10. Comparison of an Improved AFP Kit with the Intra-Amniotic PSP Dye-Injection Method in Equivocal Cases of Preterm Premature Rupture of the Fetal Membranes

Author

Yamada, Hideto, primary, Kishida, Tatsuro, additional, Negishi, Hiroaki, additional, Sagawa, Tadashi, additional, Yamaguchi, Masayuki, additional, Sato, Chikara, additional, Nakamura, Itsuro, additional, Sato, Hiroshi, additional, Sakai, Keiichiro, additional, Yamaguchi, Tatsumi, additional, and Fujimoto, Seiichiro, additional

Published
1997
Full Text
View/download PDF

17. A case of the ovarian Sertoli-Leydig cell tumor.

Author

HAREYAMA, Hitoshi, primary, TAKEDA, Naoki, additional, YAMAGUCHI, Tatsumi, additional, HATTORI, Kootarou, additional, ISHIZAKI, Yoshiaki, additional, KANEMOTO, Toshitaka, additional, YAMAGUCHI, Jun, additional, and MINASE, Takashi, additional

Published
1984
Full Text
View/download PDF

18. [Remarkably reduced tumor marker SCC levels by combined chemotherapy of paclitaxel and S-1 in two cases of advanced cervical cancer].

Author

Takagi K, Kougo H, Aoyagi Y, Yonehara T, Minobe S, Azuma M, and Yamaguchi T

Subjects
Adult, Aged, Drug Combinations, Female, Humans, Magnetic Resonance Imaging, Neoplasm Staging, Treatment Failure, Uterine Cervical Neoplasms pathology, Uterine Cervical Neoplasms radiotherapy, Antigens, Neoplasm blood, Antineoplastic Combined Chemotherapy Protocols therapeutic use, Biomarkers, Tumor blood, Oxonic Acid therapeutic use, Paclitaxel therapeutic use, Serpins blood, Tegafur therapeutic use, Uterine Cervical Neoplasms blood, Uterine Cervical Neoplasms drug therapy
Abstract

Case 1: A-35-year-old woman was diagnosed as cervical cancer Stage IIIb. When admitted to the hospital, her tumor marker SCC level was 50 ng/mL. Concurrent chemoradiation therapy was started on November, 2005. The SCC level was reduced by 0.9 ng/mL in February, 2006. In April, tumor recurrence was found by PET, and chemotherapy was restarted, but the SCC level was increased. In September, paclitaxel/S-1 therapy was performed, and the tumor markers were again reduced remarkably (SCC 9.8--> 1.3 ng/mL). Case 2: A-78-year-old woman was diagnosed as cervical cancer Stage IIIb. In August, 2004, concurrent chemoradiation therapy was started, and tumor markers were reduced (SCC 25.4--> 1.8 ng/mL). However, tumor markers were increased soon after the therapy. Chemotherapy was started, but it could not be maintained because of the side effects. In April, 2006, paclitaxel/S-1 therapy was performed, and the tumor markers were reduced remarkably (SCC 120--> 10 ng/mL). However, that therapy could also not be maintained because of the side effect. In July, she died of the cancer.

Published
2008

Catalog

Books, media, physical & digital resources
See catalog results